MDWD insider trading
NasdaqGM HealthcareMediWound Ltd. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About MediWound Ltd.
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Company website: www.mediwound.com
MDWD insider activity at a glance
FilingIQ has scored 6 insider transactions for MDWD since May 29, 2026. The most recent filing in our index is dated Jun 3, 2026.
Across the full history, 6 open-market purchases
and 0 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on MDWD insider trades is 47.2/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for MDWD?
- FilingIQ tracks 6 Form 4 insider transactions for MDWD (MediWound Ltd.), covering filings from May 29, 2026 onwards. 6 of those were filed in the last 90 days.
- Are MDWD insiders net buyers or net sellers?
- Across the full Form 4 history for MDWD, 6 transactions (100%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does MDWD insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is MDWD in?
- MediWound Ltd. (MDWD) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $184.17M.
Methodology & sources
Every MDWD insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.